Chief Executive Officer
Lawrence Patrick serves as the Chief Executive Officer of the Imperial College London Diabetes Centre (ICLDC). In this capacity, he provides strategic leadership and direction towards achieving the Centre’s emerging growth objectives.
With 20 years of experience in healthcare, Lawrence's areas of expertise include continuous quality improvement, patient satisfaction initiatives, and facility planning and development.
Prior to joining ICLDC, he served as Managing Director for the Asia region at Johns Hopkins Medicine International, overseeing the company’s international business across the continent. He concurrently served as CEO of the Johns Hopkins Singapore International Medical Centre and Tokyo Midtown Medical Center, in Japan, a Johns Hopkins affiliate. Lawrence also managed the Johns Hopkins University Division of Biomedical Sciences.
He holds a Master’s Degree in Health Administration from the Medical College of Virginia and a Bachelor’s Degree in Economics from the University of Washington in the United States.
Acting Executive Director
Dr Alya Saif Faris Ghanem Al Mazrouei serves as Acting Executive Director for Imperial College London Diabetes Centre (ICLDC). In this capacity, she provides strategic leadership and direction towards achieving the Centre’s emerging growth objectives.
Dr Alya combines her extensive surgical experience with a strong record of effective healthcare management. She served as CEO of the largest hospital in the UAE for more than five years, while also being experienced in multi-site management and leading a team in polytrauma and critical cases.
As a consultant surgeon, she is qualified in visceral, bariatric, and proctology surgery. She completed her Bachelor of Medicine, Bachelor of Surgery degree at Dubai Medical College, followed by her Doctorate in Geneva, Switzerland, and extensive further training internationally. She is a Fellow of the Royal College of Physicians of London (UK); a Member of the Royal College of Physicians and Surgeons, Glasgow (UK), and a Surgeon of Excellence in Bariatric Surgery (SRC), USA.
Consultant Endocrinologist and Diabetologist
Dr Emad has been Medical Director for Imperial College London Diabetes Centre (ICLDC) from March 2020. He joined ICLDC in 2015 after 16 years as a Consultant Physician with a specialist interest in Diabetes & Endocrinology in the UK. He graduated from the University of Cambridge where he also obtained his MD for research into hypoglycaemia unawareness.
He has a longstanding interest in Medical Education with a number of roles in the UK including being an Associate Postgraduate Dean in the East of England At ICLDC he led on medical educational activities until his change in role.
He is also a Fellow of the Royal College of Physicians of London and an MRCP PACES examiner, examining regularly in Dubai/ Sharjah.
Deputy Medical Director
Consultant Endocrinologist and Diabetologist
Dr Hawaa Al Mansouri is one of the first of a new generation of Emiratis to specialise in a career in medicine. She was awarded the prestigious Presidential Scholarship to study in the U.S in 1999 and became the first non-American woman to graduate from George Washington University School of Medicine & Health Sciences. She has extensive experience in the field of population genetics and a keen interest in linking basic science bench work to solving clinical issues, with additional, valuable experience in the care of patients at National Institutes of Health (NIH), a leading research institute. Since completing her endocrinology training in the U.S, she has become a leading figure in the regional study and practice of endocrinology and diabetes.
She is an innovator and entrepreneur, contributing not only to new schools of thought in her areas of specialism, but is also the inventor of an ultrasound-compatible FDA-approved guide wire introducer for peripheral access, the Sonostik, which will soon be in production in the United Arab Emirates. She was presented at the 2014 UAE. Government Summit by H.H. Sheikh Mansour bin Zayed Al Nahyan as an example of success in education and innovation. For her innovative efforts, she received the prestigious "Firsts in the UAE" award, granted by H.H Mohammed bin Rashid Al Maktoum. Since then she has presented and acted as Master of Ceremonies at events such as the World Government Summit.
Dr Hawaa was appointed Deputy Medical Director at Imperial College London Diabetes Centre in 2016, the region’s leading one-stop-shop for diabetes treatment, research, awareness and professional education, and focuses on lifestyle practices as an effective measurement tool for managing, preventing and even reversing diabetes for her patients at the clinic.
Information Technology Director
As Director of Information Technology (IT) and a member of the Executive Team at Imperial College London Diabetes Centre (ICLDC), Shadi Dweik is responsible for setting and implementing the IT vision and strategy ultimately helping patients, physicians and staff experience for better outcomes through technology.
Shadi oversees ICLDC’s IT department ensuring support for clinical, operational, and administrative functions through the deployment of ICLDC’s health information system, IT infrastructure, applications portfolio, project management, and technical support services. With ICLDC from day one, Shadi has worked on large scale, strategic projects including expansion and integration initiatives involving IT infrastructure set-up across all ICLDC branches, thereby facilitating seamless coordination of patient care across all sites.
Shadi brings nearly 15 years of experience to the role including a number of years at leading regional ICT service providers, Injazat Data Systems (wholly-owned by Mubadala) and the Integrated Technology Group (ITG) in Jordan.
Jaber Almehrzi serves as the Director of Administration for Imperial College London Diabetes Centre (ICLDC). In this capacity, he manages the Operations Department across all branches of the Centre and oversees several key functions including strategic planning and project management. He also works with senior management to define and develop strategy, innovation and expansion programmes at ICLDC and across the Mubadala Health network, in which ICDLC is a partner.
Prior to joining ICLDC, Mr Almehrzi worked across Mubadala Investment Company and its assets for more than 10 years. He held multiple positions in business development and operations management, focusing on Mubadala Health assets.
Mr Almehrzi holds a BSc Biomedical Engineering from Marquette University (USA), and has completed level I of the Certified Financial Analysis Examination.
Human Capital Director
Rahma Al Saeedi serves as Human Capital Director of Imperial College London Diabetes Centre (ICLDC). In this capacity, she enhances employee engagement and customer relationship management, maximizing productivity and profitability..
Al Saeedi has a decade of experience in human capital development. She joined ICLDC from Abu Dhabi Finance, where she was senior vice president for human resources and administration. Prior to this, she spent several years at Global Aerospace Logistics, as Head of Learning and Development.
An Emirati national, she holds a bachelor’s degree in business and management.
Marketing and Communications Director
Cecilia Verger serves as Marketing and Communications Director of Imperial College London Diabetes Centre (ICLDC). In this capacity, she manages and oversees ICLDC’s communications and marketing initiatives with the aim build and promote the centre’s reputation and image, while also elevating market awareness and driving demand for its service.
Cecilia has more than 20 years of experience in developing and executing marketing communications strategies. She started her career at Alcatel, a global telecommunications company in France, and worked in several technology companies in both the UAE and France. After relocating to Abu Dhabi, she managed the marketing and communication programs for global and local solar energy providers, before joining ICLDC in 2015.
A French national, Cecilia holds a master’s degree in Business Studies from a French Business School.
Head of Finance
Manikandan Venkataraman serves as the Head of Finance at the Imperial College London Diabetes Centre (ICLDC). In this capacity, he oversees and manages all Finance and Revenue Cycle Management (RCM) functions.
He brings to the role nearly 25 years of work experience, with more than 10 of these in the Abu Dhabi healthcare sector, as well as expertise across a broad spectrum of industries such as IT, Banking, Telecommunication and Education.
This is Manikandan's second innings at ICLDC, which he rejoined in 2019 after working as Corporate Receivable Manager for Abu Dhabi Health Services Company (SEHA) overseeing the group’s accounts receivable function. Prior to that he was at ICLDC for a period of six years overseeing the finance function of its Al Ain branch, as well as managing key financial processes such as budgeting and reporting. He played an instrumental role in transforming the reporting and business intelligence function at ICLDC.
Manikandan holds a Bachelor’s degree in Business Administration and is also an associate member of some of the most renowned institutes around the globe including The Chartered Institute of Management Accountant (CIMA) UK, The Certified Public Accountants (CPA) Australia, The Institute of Costs Accountants of India (CMA) and Chartered Global Management Accountant (CGMA).